Perspectives on expedited partner therapy for chlamydia: a survey of health care providers

E. A. Rosenfeld, J. Marx, M. A. Terry, R. Stall, J. Flatt, S. Borrero, E. Miller

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

There is a lack of research on health care providers’ use of and perspectives on expedited partner therapy in a state where expedited partner therapy is not prohibited or explicitly allowed. The aim of our study was to understand if and how health care providers use expedited partner therapy, if specific demographic factors and knowledge contribute to increased use of expedited partner therapy, and to describe barriers and facilitators to the use of expedited partner therapy in Pittsburgh, Pennsylvania. A convenience sample of 112 health care providers from diverse disciplines who treat young women at risk for chlamydia completed an online survey. About 11% of health care providers used expedited partner therapy consistently. Those who self-reported that they were knowledgeable about expedited partner therapy were more likely to use expedited partner therapy (73% vs. 49%, p =.009) as were those who said no or were unsure about their institution’s guidelines for expedited partner therapy (35% vs. 22%, p = 0.01) (62% vs. 57%, p = 0.01). The most commonly reported facilitator of expedited partner therapy was having clear legal guidelines (86%). This study finds that in a setting where expedited partner therapy is not expressly permitted, health care providers still use the practice but also experience barriers that limit uptake. Legislation expressly endorsing expedited partner therapy in the state and in medical institutions is needed to increase expedited partner therapy use.

Original languageEnglish (US)
Pages (from-to)1180-1186
Number of pages7
JournalInternational Journal of STD and AIDS
Volume27
Issue number13
DOIs
StatePublished - Nov 1 2016
Externally publishedYes

Fingerprint

Chlamydia
Health Personnel
Therapeutics
Surveys and Questionnaires
Guidelines
Legislation

Keywords

  • Expedited partner therapy
  • providers
  • sexually transmitted infection
  • survey
  • treatment

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Rosenfeld, E. A., Marx, J., Terry, M. A., Stall, R., Flatt, J., Borrero, S., & Miller, E. (2016). Perspectives on expedited partner therapy for chlamydia: a survey of health care providers. International Journal of STD and AIDS, 27(13), 1180-1186. https://doi.org/10.1177/0956462415610689

Perspectives on expedited partner therapy for chlamydia : a survey of health care providers. / Rosenfeld, E. A.; Marx, J.; Terry, M. A.; Stall, R.; Flatt, J.; Borrero, S.; Miller, E.

In: International Journal of STD and AIDS, Vol. 27, No. 13, 01.11.2016, p. 1180-1186.

Research output: Contribution to journalArticle

Rosenfeld, EA, Marx, J, Terry, MA, Stall, R, Flatt, J, Borrero, S & Miller, E 2016, 'Perspectives on expedited partner therapy for chlamydia: a survey of health care providers', International Journal of STD and AIDS, vol. 27, no. 13, pp. 1180-1186. https://doi.org/10.1177/0956462415610689
Rosenfeld, E. A. ; Marx, J. ; Terry, M. A. ; Stall, R. ; Flatt, J. ; Borrero, S. ; Miller, E. / Perspectives on expedited partner therapy for chlamydia : a survey of health care providers. In: International Journal of STD and AIDS. 2016 ; Vol. 27, No. 13. pp. 1180-1186.
@article{1653c10121c24a5c97f1d94bad7bffbf,
title = "Perspectives on expedited partner therapy for chlamydia: a survey of health care providers",
abstract = "There is a lack of research on health care providers’ use of and perspectives on expedited partner therapy in a state where expedited partner therapy is not prohibited or explicitly allowed. The aim of our study was to understand if and how health care providers use expedited partner therapy, if specific demographic factors and knowledge contribute to increased use of expedited partner therapy, and to describe barriers and facilitators to the use of expedited partner therapy in Pittsburgh, Pennsylvania. A convenience sample of 112 health care providers from diverse disciplines who treat young women at risk for chlamydia completed an online survey. About 11{\%} of health care providers used expedited partner therapy consistently. Those who self-reported that they were knowledgeable about expedited partner therapy were more likely to use expedited partner therapy (73{\%} vs. 49{\%}, p =.009) as were those who said no or were unsure about their institution’s guidelines for expedited partner therapy (35{\%} vs. 22{\%}, p = 0.01) (62{\%} vs. 57{\%}, p = 0.01). The most commonly reported facilitator of expedited partner therapy was having clear legal guidelines (86{\%}). This study finds that in a setting where expedited partner therapy is not expressly permitted, health care providers still use the practice but also experience barriers that limit uptake. Legislation expressly endorsing expedited partner therapy in the state and in medical institutions is needed to increase expedited partner therapy use.",
keywords = "Expedited partner therapy, providers, sexually transmitted infection, survey, treatment",
author = "Rosenfeld, {E. A.} and J. Marx and Terry, {M. A.} and R. Stall and J. Flatt and S. Borrero and E. Miller",
year = "2016",
month = "11",
day = "1",
doi = "10.1177/0956462415610689",
language = "English (US)",
volume = "27",
pages = "1180--1186",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "13",

}

TY - JOUR

T1 - Perspectives on expedited partner therapy for chlamydia

T2 - a survey of health care providers

AU - Rosenfeld, E. A.

AU - Marx, J.

AU - Terry, M. A.

AU - Stall, R.

AU - Flatt, J.

AU - Borrero, S.

AU - Miller, E.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - There is a lack of research on health care providers’ use of and perspectives on expedited partner therapy in a state where expedited partner therapy is not prohibited or explicitly allowed. The aim of our study was to understand if and how health care providers use expedited partner therapy, if specific demographic factors and knowledge contribute to increased use of expedited partner therapy, and to describe barriers and facilitators to the use of expedited partner therapy in Pittsburgh, Pennsylvania. A convenience sample of 112 health care providers from diverse disciplines who treat young women at risk for chlamydia completed an online survey. About 11% of health care providers used expedited partner therapy consistently. Those who self-reported that they were knowledgeable about expedited partner therapy were more likely to use expedited partner therapy (73% vs. 49%, p =.009) as were those who said no or were unsure about their institution’s guidelines for expedited partner therapy (35% vs. 22%, p = 0.01) (62% vs. 57%, p = 0.01). The most commonly reported facilitator of expedited partner therapy was having clear legal guidelines (86%). This study finds that in a setting where expedited partner therapy is not expressly permitted, health care providers still use the practice but also experience barriers that limit uptake. Legislation expressly endorsing expedited partner therapy in the state and in medical institutions is needed to increase expedited partner therapy use.

AB - There is a lack of research on health care providers’ use of and perspectives on expedited partner therapy in a state where expedited partner therapy is not prohibited or explicitly allowed. The aim of our study was to understand if and how health care providers use expedited partner therapy, if specific demographic factors and knowledge contribute to increased use of expedited partner therapy, and to describe barriers and facilitators to the use of expedited partner therapy in Pittsburgh, Pennsylvania. A convenience sample of 112 health care providers from diverse disciplines who treat young women at risk for chlamydia completed an online survey. About 11% of health care providers used expedited partner therapy consistently. Those who self-reported that they were knowledgeable about expedited partner therapy were more likely to use expedited partner therapy (73% vs. 49%, p =.009) as were those who said no or were unsure about their institution’s guidelines for expedited partner therapy (35% vs. 22%, p = 0.01) (62% vs. 57%, p = 0.01). The most commonly reported facilitator of expedited partner therapy was having clear legal guidelines (86%). This study finds that in a setting where expedited partner therapy is not expressly permitted, health care providers still use the practice but also experience barriers that limit uptake. Legislation expressly endorsing expedited partner therapy in the state and in medical institutions is needed to increase expedited partner therapy use.

KW - Expedited partner therapy

KW - providers

KW - sexually transmitted infection

KW - survey

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84992691576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992691576&partnerID=8YFLogxK

U2 - 10.1177/0956462415610689

DO - 10.1177/0956462415610689

M3 - Article

C2 - 26446138

AN - SCOPUS:84992691576

VL - 27

SP - 1180

EP - 1186

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 13

ER -